VEEV Stock Recent News

Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Veeva's shares have had a rocky ride, but its latest financial results were positive. The life sciences-focused cloud company has a strong moat and a long runway

Veeva reported better-than-expected sales and earnings in August. The stock's valuation ratios tumbled, while it lagged major indexes over the past year.

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- TransPerfect , the world's largest provider of language and AI solutions for global business, today announced it has achieved Veeva Gold Certified Product Partner status and is a new Veeva AI Partner. By earning gold certification as a Veeva Product Partner and joining the new Veeva AI Partner Program , TransPerfect strengthens its position as a leader and trusted partner in delivering innovative generative AI solutions in the translation space.

Review Veeva's (VEEV) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

New capabilities and simple, standard site experience cut trial time and expense Fixed price implementation to get up and running quickly Industry advances to connected trials as seven of the top 20 biopharmas adopt Veeva Site Connect PLEASANTON, Calif. , Sept. 5, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced, in a major step forward for clinical trial execution, the newest release of Veeva Site Connect, adding powerful new capabilities and a streamlined site-centric experience to simplify and standardize sponsor-site collaboration.

PLEASANTON, Calif. , Aug. 30, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conference: Citi 2024 Global TMT Conference, New York, NY.

I upgraded Veeva to “buy” in my previous post as I believed that the company was starting to see acceleration in top and bottom lines, with the stock up 19%since. The company reported its Q2 FY25 earnings where revenue and earnings grew 15% and 32% YoY beating estimates, driven by momentum in its R&D Solutions and an acceleration in Commercial Cloud. Despite strong Q2 performance, the management didn't raise FY25 revenue guidance, although it expanded its outlook for non-GAAP income from operations, boosting investor sentiment.

Veeva beat analysts' quarterly expectations. Veeva's bottom line impressed investors, as earnings are growing faster than revenue.